Soleno Therapeutics Inc —— 资产负债表 (NASDAQ:SLNO) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 64.98 M35.55 M26.5 M180.69 M330.97 M563.83 M 负债总额 19.43 M17.76 M16.15 M23.18 M85.86 M113.72 M 权益总额 45.55 M17.79 M10.35 M157.51 M245.11 M450.12 M 负债及股东权益总额 64.98 M35.55 M26.5 M180.69 M330.97 M563.83 M 总债务 ————49.83 M49.86 M 净债务 ————-241.61 M-255.61 M

新闻

Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why

Soleno Acquisition: Assessing The $50 Per Share Price Tag (NASDAQ:SLNO)

Wall Street Breakfast Podcast: PepsiCo Exits Kanye Fest

Neurocrine wants to develop new obesity drugs. It’s making an acquisition to accelerate that move.

M&A News: Soleno Therapeutics Stock (SLNO) Surges 28% as Neurocrine Biosciences Lines up $2.5B Deal - TipRanks.com

US stock futures edge up as investors assess Mideast ceasefire prospects

Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD)

AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights

Soleno Therapeutics修订公司章程以更新治理和法律条款

H.C. Wainwright下调Soleno Therapeutics目标价至100美元

H.C. Wainwright cuts Soleno Therapeutics stock price target to $100

Soleno Therapeutics stock hits 52-week low at 36.01 USD